Type of Study:
Cardiovascular
Study Length:
3.5 – 5 years
Target Age/Sex:
over 50 years of age, Male and Female
Benefits:
Participants will receive at no cost: study product, study materials and study-specific procedures
Link: ClinicalTrials.gov
Staus: Enrolling
Description:
Semaglutide Cardiovascular Outcomes Trial in Patients With Type 2 Diabetes.
